Jane Street’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$974K Sell
117,315
-278,142
-70% -$2.88M ﹤0.01% 6548
2025
Q4
$4.89M Buy
+395,457
New +$4.24M 0.01% 3256
2025
Q3
Sell
-46,609
Closed -$363K 11017
2025
Q2
$297K Sell
46,609
-52,781
-53% -$302K ﹤0.01% 7879
2025
Q1
$483K Sell
99,390
-80,275
-45% -$664K ﹤0.01% 6930
2024
Q4
$1.72M Buy
179,665
+32,345
+22% +$297K ﹤0.01% 4395
2024
Q3
$1.23M Sell
147,320
-343,430
-70% -$3.12M ﹤0.01% 5464
2024
Q2
$3.35M Buy
490,750
+367,574
+298% +$1.58M ﹤0.01% 3627
2024
Q1
$312K Sell
123,176
-123,841
-50% -$279K ﹤0.01% 7500
2023
Q4
$593K Sell
247,017
-393,410
-61% -$925K ﹤0.01% 6476
2023
Q3
$2.18M Buy
640,427
+527,061
+465% +$2.92M ﹤0.01% 3907
2023
Q2
$833K Buy
113,366
+80,872
+249% +$750K ﹤0.01% 5518
2023
Q1
$337K Buy
+32,494
New +$393K ﹤0.01% 6998
2022
Q4
Sell
-33,793
Closed -$523K 9358
2022
Q3
$709K Buy
+33,793
New +$940K ﹤0.01% 6043
2022
Q2
Sell
-47,599
Closed -$1.63M 9921
2022
Q1
$1.96M Sell
47,599
-12,113
-20% -$534K ﹤0.01% 4809
2021
Q4
$2.6M Buy
59,712
+16,319
+38% +$738K 0.01% 3965
2021
Q3
$2.17M Buy
43,393
+13,546
+45% +$820K 0.01% 4309
2021
Q2
$1.88M Buy
29,847
+7,906
+36% +$508K ﹤0.01% 4440
2021
Q1
$2.04M Sell
21,941
-21,767
-50% -$2.23M 0.01% 3977
2020
Q4
$3.92M Buy
43,708
+9,188
+27% +$843K 0.01% 2441
2020
Q3
$3.57M Sell
34,520
-10,168
-23% -$1.1M 0.01% 2230
2020
Q2
$3.53M Buy
44,688
+39,254
+722% +$2.93M 0.01% 2279
2020
Q1
$314K Buy
5,434
+432
+9% +$24.9K ﹤0.01% 4145
2019
Q4
$270K Sell
5,002
-832
-14% -$45.1K ﹤0.01% 4402
2019
Q3
$305K Buy
+5,834
New +$272K ﹤0.01% 4167
2017
Q1
Sell
-6,985
Closed -$229K 4260
2016
Q4
$229K Buy
+6,985
New +$209K ﹤0.01% 3618
2016
Q1
Sell
-5,770
Closed -$231K 4181
2015
Q4
$231K Buy
+5,770
New +$201K ﹤0.01% 3413
2014
Q1
Sell
-14,430
Closed -$332K 2752
2013
Q4
$332K Buy
14,430
+275
+2% +$5.73K 0.01% 1572
2013
Q3
$270K Buy
+14,155
New +$253K 0.01% 2185

Other funds holding EBS